Head

Genius Group Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program

Retrieved on: 
星期五, 五月 3, 2024
Ecosystem, Learning, AI, School, City, Communication, Artificial intelligence, Curriculum, GNS, Acquisition, CFA, Workforce, Head, COVID-19

Singapore, May 03, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) ("Genius Group" or the "Company"), a leading provider of AI-powered, digital-first education solutions, today announced the engagement of international investor relations specialists MZ Group (“MZ”) to lead a strategic investor relations and financial communications program across all key markets.

Key Points: 
  • Singapore, May 03, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) ("Genius Group" or the "Company"), a leading provider of AI-powered, digital-first education solutions, today announced the engagement of international investor relations specialists MZ Group (“MZ”) to lead a strategic investor relations and financial communications program across all key markets.
  • MZ Group will work closely with Genius Group’s management to build upon their investor relations and shareholder communications program designed to increase the Company’s visibility throughout the investment community.
  • MZ has developed a distinguished reputation as a premier resource for institutional investors, brokers, analysts, and private investors.
  • We look forward to working closely with Brian and the team at MZ Group as we strive to deliver sustainable, long-term value to our shareholders.”

DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck

Retrieved on: 
星期五, 五月 3, 2024
Surgery, Genetics, Clinical Trials, Biotechnology, Biometrics, Health, Pharmaceutical, General Health, Oncology, Radiation, Mohs, NCCN, Mohs surgery, American College, CME, ACMS, Abstract (summary), Neck, National Comprehensive Cancer Network, SCC, Patient, Metastasis, Neoplasm, Head, BWH

“In most cases, once a tumor is removed completely, the patient is in the clear.

Key Points: 
  • “In most cases, once a tumor is removed completely, the patient is in the clear.
  • This study included 417 patients who received definitive Mohs surgery to remove high-risk SCC tumors of the H&N with reported clear margins.
  • Presenting authors will be available to answer questions regarding their posters on Saturday, May 4, from 12-1 p.m. Mountain Standard Time.
  • Abstracts will also be in ACMS' CME & Abstract Book and available for online viewing via the Planstone abstract site.

Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health

Retrieved on: 
星期五, 五月 3, 2024
Health, Neurology, Genetics, Research, Science, Pharmaceutical, Biotechnology, Neuromuscular disease, SRPT, National academy, DSM-IV codes, Hospital, Muscular dystrophy, Book, SMA, Cell, Duchenne, Disease, TIME, Patient, Sarepta Therapeutics, Gene, Society, Nationwide, Duchenne muscular dystrophy, Head, Therapy, Global health, Pharmaceutical industry

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that TIME named renown neuromuscular researcher, physician and gene therapy pioneer Jerry R. Mendell, M.D., to the inaugural 2024 TIME100 Health, a list of 100 individuals who most influenced global health this year.

Key Points: 
  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that TIME named renown neuromuscular researcher, physician and gene therapy pioneer Jerry R. Mendell, M.D., to the inaugural 2024 TIME100 Health, a list of 100 individuals who most influenced global health this year.
  • The TIME100 Health list recognizes the impact, innovation, and achievement of the world’s most influential individuals in health.
  • In addition to recognition on the TIME100 Health list, Dr. Mendell is a 2024 recipient of the King Faisal Prize Laureate in Medicine.
  • He is also a published author of more than 400 peer-reviewed articles and books about skeletal muscle disease, peripheral nerve disorders and gene therapy.

Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis

Retrieved on: 
星期四, 五月 2, 2024
Technology, Medical Devices, Medical Supplies, Infectious Diseases, Genetics, Clinical Trials, Biotechnology, Health, Artificial Intelligence, AbCellera, CFO, University, Cancer, SoftBank Vision Fund, Antimicrobial resistance, Bone marrow, HBM, Pneumonia, Head, Risk, Hospital, Metagenomics, Infection, Survival, AMR, Public, Eli Lilly, Khosla Ventures, Partnership, University of California, Research, Artificial intelligence, DNA, Partner (business rank), Transplant, Patient, Immunodeficiency, Eric Schmidt, General partnership, MD Anderson Cancer Center, Death, Growth, Pharmaceutical industry

Karius® , Inc., a world leader in genomic diagnostics for infectious disease, today announced it has secured $100 million in Series C funding.

Key Points: 
  • Karius® , Inc., a world leader in genomic diagnostics for infectious disease, today announced it has secured $100 million in Series C funding.
  • The round was co-led by Khosla Ventures and new investors 5AM Ventures and Gilde Healthcare.
  • The funding enables Karius to address increasing demand from healthcare providers to expand access to the Karius Test beyond the hospital setting.
  • Additionally, it will support research into the broader health implications of Karius’ microbial cell-free DNA technology beyond infectious diseases.

ServiceNow’s Expanded Scope Boosts Uptake in Australia

Retrieved on: 
星期五, 五月 3, 2024
Professional Services, Data Management, Security, Data Analytics, Technology, Human Resources, Consulting, Knowledge, AC3, ITSM, Ecosystem, KPMG, Infosys, TCS, HR, Wipro, Research, Kinetic, ISG, Automation, Fujitsu, Knowledge extraction, Synthetic media, Research report, Customer, Human voice, Head, Telecommunications, Name, Algorithm, Organization, Growth, Accenture, Voice of the customer, HCLTech, Risk management

Last year, growth in ServiceNow adoption in Australia likely surpassed the company’s global growth rate, the ISG report noted.

Key Points: 
  • Last year, growth in ServiceNow adoption in Australia likely surpassed the company’s global growth rate, the ISG report noted.
  • “Australian enterprises already trust ServiceNow for ITSM,” said Michael Gale, partner and head of ISG Asia Pacific.
  • Due to the high cost of extensive ServiceNow deployments, the company’s Australian customer base is predominantly in large enterprises.
  • In the area of customer experience, KPMG is named the global ISG CX Star Performer for 2024 among ServiceNow ecosystem partners.

Anoki Elevates Personalized Content Discovery with AI-Powered Experience on Google TV

Retrieved on: 
星期四, 五月 2, 2024
Software, Mobile, Wireless, Entertainment, Internet, Technology, Artificial Intelligence, General Entertainment, TV and Radio, Advertising, Communications, Content Marketing, Other Technology, Google TV, Multimedia, Original equipment manufacturer, Head, Connected, CTV, Sales

Anoki , a leader in generative AI for Connected TVs (CTV), today announced the launch of Live TVx, a groundbreaking free streaming service on Google TV devices.

Key Points: 
  • Anoki , a leader in generative AI for Connected TVs (CTV), today announced the launch of Live TVx, a groundbreaking free streaming service on Google TV devices.
  • Live TVx marks a significant leap forward in personalized content discovery, utilizing advanced Anoki AI to curate and prioritize channels based on individual user viewing habits.
  • View the full release here: https://www.businesswire.com/news/home/20240502212690/en/
    Anoki announced Live TVx, a groundbreaking free streaming service on Google TV devices.
  • Personalized for Every Moment "Anoki leverages the power of AI to personalize the experience for each user and ensure that they see the content they truly want, when they want it,” said Raghu Kodige, CEO of Anoki.

Zero-Emission Trucks - IDTechEx Explores Electric and Fuel Cell Trucks

Retrieved on: 
星期五, 五月 3, 2024
Online, Hydrogen, City, Investment, Weather, Transport, Environment, Legislation, Electricity, Head, CO2, Atmosphere, Growth, Renewable energy

Online shopping won't have to be such a large contributor to emissions because electric and fuel cell trucks won't negatively impact the environment with deliveries.

Key Points: 
  • Online shopping won't have to be such a large contributor to emissions because electric and fuel cell trucks won't negatively impact the environment with deliveries.
  • Electric and fuel cell trucks could be a window to turning these figures on their head, and over the past few years, battery electric trucks have moved from prototypes to commercial models.
  • In their report on the topic, " Electric and Fuel Cell Trucks 2024-2044: Markets, Technologies, and Forecasts ", IDTechEx predicts that by 2044 82% of zero-emission trucks sold will be battery electric out of approximately 1.8 million zero-emission trucks sold per year.
  • For more information, please see the IDTechEx reports " Electric and Fuel Cell Trucks 2024-2044: Markets, Technologies, and Forecasts " and " Fuel Cell Electric Vehicles 2024-2044: Markets, Technologies, and Forecasts ".

Zero-Emission Trucks - IDTechEx Explores Electric and Fuel Cell Trucks

Retrieved on: 
星期五, 五月 3, 2024
Online, Hydrogen, City, Investment, Weather, Transport, Environment, Legislation, Electricity, Head, CO2, Atmosphere, Growth, Renewable energy

Online shopping won't have to be such a large contributor to emissions because electric and fuel cell trucks won't negatively impact the environment with deliveries.

Key Points: 
  • Online shopping won't have to be such a large contributor to emissions because electric and fuel cell trucks won't negatively impact the environment with deliveries.
  • Electric and fuel cell trucks could be a window to turning these figures on their head, and over the past few years, battery electric trucks have moved from prototypes to commercial models.
  • In their report on the topic, " Electric and Fuel Cell Trucks 2024-2044: Markets, Technologies, and Forecasts ", IDTechEx predicts that by 2044 82% of zero-emission trucks sold will be battery electric out of approximately 1.8 million zero-emission trucks sold per year.
  • For more information, please see the IDTechEx reports " Electric and Fuel Cell Trucks 2024-2044: Markets, Technologies, and Forecasts " and " Fuel Cell Electric Vehicles 2024-2044: Markets, Technologies, and Forecasts ".

Harvest Portfolios Group Inc. Opens the Market

Retrieved on: 
星期五, 五月 3, 2024
Fixed income, Multimedia, Toronto Stock Exchange, TSX, HBIG, Head, AUM, Investment fund, Financial adviser

TORONTO, May 3, 2024 /PRNewswire/ - Michael Kovacs, Chief Executive Officer, Harvest ETFs, Harvest Portfolios Group Inc., and his team joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange (TSX), to open the market and celebrate the launch of three new ETFs: the Harvest Balanced Income & Growth ETF (TSX: HBIG), the Harvest Balanced Income & Growth Enhanced ETF (TSX: HBIE), and the Harvest Industrial Leaders Income ETF (TSX: HIND).

Key Points: 
  • TORONTO, May 3, 2024 /PRNewswire/ - Michael Kovacs, Chief Executive Officer, Harvest ETFs, Harvest Portfolios Group Inc., and his team joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange (TSX), to open the market and celebrate the launch of three new ETFs: the Harvest Balanced Income & Growth ETF (TSX: HBIG), the Harvest Balanced Income & Growth Enhanced ETF (TSX: HBIE), and the Harvest Industrial Leaders Income ETF (TSX: HIND).
  • Founded in 2009, Harvest ETFs is an independent Canadian Investment Fund Manager with over $4.1 billion in AUM.
  • Harvest has expanded its income philosophy to introduce Fixed Income ETFs and Balanced Income ETFs to our innovative lineup.
  • Harvest has incorporated equity and fixed income, and integrated our strategic covered call strategy, which is designed to deliver higher yields and increase monthly income for our clients.

Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry

Retrieved on: 
星期五, 五月 3, 2024
Laboratory, Head, Laminar, Partnership, Doctor of Philosophy, Research, Vaccine, Automation, Flow cytometry

The agreement combines the Laminar flow-based gentle liquid exchange technology known as C-FREE™ technology from Curiox with the comprehensive suite of DURAClone dry pre-formulated antibody panels and customized DURA Innovations dry reagent antibody cocktails from Beckman Coulter Life Sciences.

Key Points: 
  • The agreement combines the Laminar flow-based gentle liquid exchange technology known as C-FREE™ technology from Curiox with the comprehensive suite of DURAClone dry pre-formulated antibody panels and customized DURA Innovations dry reagent antibody cocktails from Beckman Coulter Life Sciences.
  • This workflow solution overcomes longstanding challenges faced by researchers worldwide, including the need for highly standardized, reproducible, and automated sample preparation for flow cytometry laboratories.
  • "Our alliance with Beckman Coulter Life Sciences is not just about combining technologies; it's about combining our strengths to empower the scientific community," said Namyong Kim.
  • "This partnership presents an exciting step forward in redefining the standards of quality and efficiency in flow cytometry research.